drugset / Trial / NCT03393702

Pain Control in Children and Adolescent After Thoracic Surgery: The Effect of Gabapentin

NCT03393702

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is performed in patients aged 5-18 years after thoracic surgery. The primary aim of this trial is to determine whether the use of gabapentin as a component of multimodal analgesic regiments reduces pain scores following thoracic surgery in pediatric patients. The secondary objective of the trial are to evaluate whether the use of gabapentin reduces postoperative anxiety scores and consumption of ropivacaine with fentanyl, decreases side-effects, and improves patient satisfaction.

Timeline

Start
2017-05-09
Primary completion
2019-12-30
Completion
2020-12-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 7.5 mg/kg Oral

Indications